Has Ralph Zagha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $459,384 in general payments to Ralph Zagha, MD across 196 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ralph Zagha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ralph Zagha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ralph Zagha, MD

Urology · Lauderdale Lakes, FLNPI 1063450773

Payments from drug & device makers

$459,384in general payments, 2019–2025

Across 196 payments — averaging $2343.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

IBSA Institut Biochimique SA$322K
Ironwood Pharmaceuticals, Inc$60K
Urovant Sciences Inc$57K
Sumitomo Pharma America, Inc.$10K
AbbVie$6K
Procept Biorobotics Corporation$478
plus $3K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
IBSA Institut Biochimique SA	12	$322,110
Ironwood Pharmaceuticals, Inc	17	$60,087
Urovant Sciences Inc	18	$57,156
Sumitomo Pharma America, Inc.	5	$9,835
AbbVie(2 entities)	12	$6,297
Procept Biorobotics Corporation	9	$478
Johnson & Johnson(3 entities)	12	$451
Rochester Medical Corporation	8	$441
Myriad Genetic Laboratories, Inc.	11	$301
Astellas Pharma US Inc	4	$166
Verity Pharmaceuticals Inc.	7	$164
Endo Pharmaceuticals Inc.	10	$161
Boston Scientific	2	$154
Coloplast	8	$140
Amgen	5	$134
Terumo Medical Corporation	1	$132
Endo USA, Inc.	5	$123
Olympus America Inc.	7	$111
Antares Pharma, Inc.	6	$104
Lilly USA, LLC	2	$91
C. R. Bard, Inc. & Subsidiaries	3	$71
Urogen Pharma, Inc.	3	$69
180 Medical, Inc.	2	$64
Regeneron Healthcare Solutions, Inc.	3	$63
AstraZeneca	2	$53
Teleflex LLC	2	$49
UCB, Inc.	2	$45
Pfizer	2	$44
Incyte Corporation	2	$42
Biofrontera Inc.	2	$37
Sunovion Pharmaceuticals Inc.	2	$33
Convatec Inc.	2	$32
Davol Inc.	1	$30
Boehringer Ingelheim	1	$21
Bayer	1	$19
Calyxo, Inc.	1	$17
Bristol Myers Squibb	1	$17
Tolmar, Inc.	1	$14
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$13
Agiliti Surgical, Inc.	1	$12

How this compares

$459,384 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.

See all urology providers in Florida →

Medicare billing

Part B allowed, 2024

$258,726

Medicare patients

698

Services billed

2,939

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Lauderdale Lakes

Steven KesterPompano Beach$5.7M
Harvey SamowitzHallandale Beach$3.6M
Paul PeritoCoral Gables$3.6M
Graham GreeneLakeland$2.5M
Scott SellingerTallahassee$2.3M
Fernando BiancoHialeah$2.2M
Osvaldo PadronTampa$1.3M
Mark Anthony GonzalgoMiami$1.1M
Paul CrispenGainesville$1.1M
Craig HermanPompano Beach$1.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →